3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
3
Lymphoid
3
Myeloid
1
Conditions
Myelodysplastic Syndromes
9
Precursor Cell Lymphoblastic Leukemia-Lymphoma
7
Leukemia, Myeloid, Acute
7
Multiple Myeloma
6
Leukemia
6
Leukemia, Myelomonocytic, Chronic
5
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
5
Blast Crisis
5
Lymphohistiocytosis, Hemophagocytic
4
Hodgkin Disease
4
Hematologic Neoplasms
4
Primary Myelofibrosis
3
Myeloproliferative Disorders
3
Lymphoma, Non-Hodgkin
3
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Leukemia, Hairy Cell
3
Burkitt Lymphoma
3
Blastic Plasmacytoid Dendritic Cell Neoplasm
3
Vomiting
2
Testicular Neoplasms
2
Sezary Syndrome
2
Pdgfra-Associated Chronic Eosinophilic Leukemia
2
Neuroblastoma
2
Nausea
2
Myelodysplastic-Myeloproliferative Diseases
2
Mycosis Fungoides
2
Lymphoma, T-Cell, Cutaneous
2
Lymphoma, Mantle-Cell
2
Lymphoma, Large-Cell, Immunoblastic
2
Interventions
Imatinib Mesylate
12
nilotinib
3
bosutinib
3
peginterferon alfa-2a
2
asciminib
2
Dasatinib
2
Azacitidine
2
4-methyl-N-(3-(4-methylimidazol-1-yl)-5-trifluoromethylphenyl)-3-(4-pyrazin-2-ylpyrimidin-2-ylamino)benzamide
2
venetoclax
1
thymoglobulin
1
flumatinib
1
fludarabine phosphate
1
fludarabine
1
Whole-Body Irradiation
1
Vincristine
1
Tyrosine Kinase Inhibitors
1
Tacrolimus
1
Rituximab
1
Mycophenolic Acid
1
Melphalan
1
Interferons
1
Dexamethasone
1
Clofarabine
1
Busulfan
1
Bone Marrow Transplantation
1
Blood Specimen Collection
1
Antilymphocyte Serum
1
Acetaminophen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Philadelphia Chromosome
×
Dexamethasone
×
Myeloid
×
Clear all
NCT00763763
2011-10-05
AFR07
Assistance Publique - Hôpitaux de Paris
Phase 2
Completed
55 enrolled